1. Home
  2. ARCH vs ARWR Comparison

ARCH vs ARWR Comparison

Compare ARCH & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCH
  • ARWR
  • Stock Information
  • Founded
  • ARCH 1969
  • ARWR 2003
  • Country
  • ARCH United States
  • ARWR United States
  • Employees
  • ARCH N/A
  • ARWR N/A
  • Industry
  • ARCH Coal Mining
  • ARWR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARCH Energy
  • ARWR Health Care
  • Exchange
  • ARCH Nasdaq
  • ARWR Nasdaq
  • Market Cap
  • ARCH 2.6B
  • ARWR 2.5B
  • IPO Year
  • ARCH 1988
  • ARWR 1993
  • Fundamental
  • Price
  • ARCH $167.01
  • ARWR $18.71
  • Analyst Decision
  • ARCH Buy
  • ARWR Buy
  • Analyst Count
  • ARCH 5
  • ARWR 11
  • Target Price
  • ARCH $173.60
  • ARWR $45.33
  • AVG Volume (30 Days)
  • ARCH 372.9K
  • ARWR 999.9K
  • Earning Date
  • ARCH 11-05-2024
  • ARWR 11-26-2024
  • Dividend Yield
  • ARCH 0.96%
  • ARWR N/A
  • EPS Growth
  • ARCH N/A
  • ARWR N/A
  • EPS
  • ARCH 9.67
  • ARWR N/A
  • Revenue
  • ARCH $2,645,357,000.00
  • ARWR $19,648,000.00
  • Revenue This Year
  • ARCH N/A
  • ARWR N/A
  • Revenue Next Year
  • ARCH N/A
  • ARWR $100.95
  • P/E Ratio
  • ARCH $17.38
  • ARWR N/A
  • Revenue Growth
  • ARCH N/A
  • ARWR N/A
  • 52 Week Low
  • ARCH $116.44
  • ARWR $17.05
  • 52 Week High
  • ARCH $187.60
  • ARWR $39.83
  • Technical
  • Relative Strength Index (RSI)
  • ARCH 69.15
  • ARWR 38.49
  • Support Level
  • ARCH $163.86
  • ARWR $18.18
  • Resistance Level
  • ARCH $171.87
  • ARWR $22.03
  • Average True Range (ATR)
  • ARCH 5.61
  • ARWR 0.90
  • MACD
  • ARCH 0.33
  • ARWR -0.27
  • Stochastic Oscillator
  • ARCH 85.95
  • ARWR 14.99

About ARCH Arch Resources Inc.

Arch Resources Inc is a producer of metallurgical and coking coal. The company sells its coal to power plants, steel mills, and industrial facilities. Its operating segment includes Metallurgical (MET) and Thermal. It generates maximum revenue from the Metallurgical (MET) segment. Geographically, it derives a majority of its revenue from Asia.

About ARWR Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Share on Social Networks: